Octreotide 50mcg/mL Injection

Product Introduction

Octreotide 50mcg/ml is an injectable somatostatin analogue used in supervised care for conditions where reducing hormone or gastrointestinal peptide secretion is needed. Depending on the clinical setting, octreotide may be used for acromegaly, symptoms from carcinoid tumors or VIPomas, and selected emergency uses such as variceal bleeding under specialist protocols. Octreotide can affect glucose control, causing either high or low blood sugar, especially when diabetes medicines are used or doses change. It can reduce gallbladder contraction and bile flow, leading to gallstones, biliary sludge, cholecystitis, cholangitis, pancreatitis, or abdominal pain. Thyroid function can fall during chronic therapy.

How to use

Octreotide 50mcg/ml is given by healthcare professionals by the prescribed route and schedule. Dose depends on indication and response. Keep monitoring for glucose, gallbladder symptoms, thyroid function, heart rate, and treatment response.

How it works

Octreotide mimics somatostatin and suppresses secretion of growth hormone, insulin, glucagon, and gastrointestinal peptides.

Common side effects

Possible effects include diarrhea, nausea, abdominal pain, gas, constipation, headache, dizziness, injection-site pain, and glucose changes. Serious concerns include gallstones or biliary complications, pancreatitis, slow heart rate, arrhythmia, severe glucose disturbance, hypothyroidism, and allergic reaction.

Important information

Review diabetes, gallbladder disease, pancreatitis, thyroid disease, heart rhythm disease, bradycardia, kidney or liver disease, pregnancy, breastfeeding, insulin, oral diabetes medicines, beta blockers, cyclosporine, bromocriptine, and lutetium Lu 177 dotatate plans.